Changes in Follow‐Up ECG and Signal‐Averaged ECG in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy

Electrocardiogram (ECG) and signal‐averaged ECG (SAECG) are important as diagnostic tools in arrhythmogenic right ventricular cardiomyopathy (ARVC). The aim of this study was to investigate changes in follow‐up ECGs and SAECGs in patients with ARVC.

[1]  S. Chae,et al.  Clinical manifestations of arrhythmogenic right ventricular cardiomyopathy in Korean patients. , 2007, International journal of cardiology.

[2]  T. Arentz,et al.  Epsilon-like waves and ventricular conduction abnormalities in subjects with type 1 ECG pattern of Brugada syndrome. , 2011, Heart rhythm.

[3]  D. Corrado,et al.  CARDIOMYOPATHY Arrhythmogenic right ventricular cardiomyopathy: diagnosis, prognosis, and treatment , 2022 .

[4]  Andrea Nava,et al.  Long-term follow-up of the signal-averaged ECG in arrhythmogenic right ventricular cardiomyopathy: correlation with arrhythmic events and echocardiographic findings. , 2006, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[5]  T. Ikeda,et al.  Assessment of noninvasive markers in identifying patients at risk in the Brugada syndrome: insight into risk stratification. , 2001, Journal of the American College of Cardiology.

[6]  G. Danieli,et al.  Ultrastructural evidence of intercalated disc remodelling in arrhythmogenic right ventricular cardiomyopathy: an electron microscopy investigation on endomyocardial biopsies. , 2006, European heart journal.

[7]  H. Wellens,et al.  Value of the 12-lead electrocardiogram in arrhythmogenic right ventricular dysplasia, and absence of correlation with echocardiographic findings. , 1993, The American journal of cardiology.

[8]  D. Corrado,et al.  Dispersion of Ventricular Depolarization-Repolarization: A Noninvasive Marker for Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy , 2001, Circulation.

[9]  P. Coumel,et al.  Progressive ECG changes in arrhythmogenic right ventricular disease. Evidence for an evolving disease. , 1996, European heart journal.

[10]  H. Calkins,et al.  Electrocardiographic Features of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy According to Disease Severity: A Need to Broaden Diagnostic Criteria , 2004, Circulation.

[11]  A. Angelini,et al.  Late potentials and ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy. , 1999, The American journal of cardiology.

[12]  M. Davies,et al.  Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. , 1997, Journal of the American College of Cardiology.

[13]  Y. Oade,et al.  Arrhythmogenic right ventricular cardiomyopathy , 2011, BMJ Case Reports.

[14]  Hugh Calkins,et al.  Desmosomal Dysfunction due to Mutations in Desmoplakin Causes Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy , 2006, Circulation research.

[15]  P. Lambiase,et al.  Electrophysiological abnormalities precede overt structural changes in arrhythmogenic right ventricular cardiomyopathy due to mutations in desmoplakin-A combined murine and human study , 2012, European heart journal.

[16]  Wojciech Zareba,et al.  Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria , 2010, European heart journal.

[17]  John C Chambers,et al.  Arrhythmogenic cardiomyopathy: etiology, diagnosis, and treatment. , 2010, Annual review of medicine.

[18]  G. Danieli,et al.  Mutations in Desmoglein-2 Gene Are Associated With Arrhythmogenic Right Ventricular Cardiomyopathy , 2006, Circulation.

[19]  D. Panagiotakos,et al.  Arrhythmogenic right ventricular cardiomyopathy caused by deletions in plakophilin-2 and plakoglobin (Naxos disease) in families from Greece and Cyprus: genotype-phenotype relations, diagnostic features and prognosis. , 2006, European heart journal.

[20]  G. Breithardt,et al.  Age- and Training-Dependent Development of Arrhythmogenic Right Ventricular Cardiomyopathy in Heterozygous Plakoglobin-Deficient Mice , 2006, Circulation.

[21]  S. Russell,et al.  Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. , 2013, Journal of the American College of Cardiology.

[22]  H. Calkins,et al.  Electrocardiographic findings over time in arrhythmogenic right ventricular dysplasia/cardiomyopathy. , 2005, The American journal of cardiology.

[23]  S. Chae,et al.  Correlation between the Parameters of Signal‐Averaged ECG and Two‐Dimensional Echocardiography in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy , 2009, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

[24]  Link,et al.  UvA-DARE ( Digital Academic Repository ) Pathophysiological mechanisms of arrhythmogenic right ventricular disorders , 2013 .

[25]  L. Eckardt,et al.  A prospective study on spontaneous fluctuations between diagnostic and non-diagnostic ECGs in Brugada syndrome: implications for correct phenotyping and risk stratification. , 2006, European heart journal.

[26]  A. Nava,et al.  Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. , 1994, British heart journal.

[27]  D. Malicier,et al.  Circumstances of Death and Gross and Microscopic Observations in a Series of 200 Cases of Sudden Death Associated With Arrhythmogenic Right Ventricular Cardiomyopathy and/or Dysplasia , 2003, Circulation.

[28]  C. Autore,et al.  Dynamic electrocardiographic changes in patients with arrhythmogenic right ventricular cardiomyopathy , 2010, Heart.

[29]  G. Breithardt,et al.  Standards for analysis of ventricular late potentials using high resolution or signal-averaged electrocardiography. A statement by a Task Force Committee between the European Society of Cardiology, the American Heart Association and the American College of Cardiology. , 1991, European heart journal.